Key statistics
As of last trade Akeso Inc (9926:HKG.HZ) traded at 76.80, -1.09% below its 52-week high of 77.65, set on Nov 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 72.65 |
---|---|
High | 77.65 |
Low | 72.25 |
Bid | 76.75 |
Offer | 76.80 |
Previous close | 72.20 |
Average volume | 8.67m |
---|---|
Shares outstanding | 897.56m |
Free float | 668.34m |
P/E (TTM) | -- |
Market cap | 68.93bn HKD |
EPS (TTM) | -0.9404 HKD |
Data delayed at least 15 minutes, as of Nov 25 2024.
More ▼
Press releases
- Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024
- Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024
- Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC
- Promising Anti-Tumor Activity and Safety of Ivonescimab in Combination Therapies in CRC, TNBC, and HNSCC Featured at ESMO 2024
- Summit Therapeutics Raises $235 Million
- Ivonescimab Monotherapy Reduced the Risk of Disease Progression or Death by 49% Compared to Pembrolizumab Monotherapy in First-Line Treatment of Patients with PD-L1 Positive Advanced NSCLC in China
More ▼